Fecal microbiota transplantation in cancer management: Current status and perspectives

被引:238
作者
Chen, Danfeng [1 ]
Wu, Jingyi [1 ]
Jin, Duochen [1 ]
Wang, Bangmao [1 ]
Cao, Hailong [1 ]
机构
[1] Tianjin Med Univ, Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin 300052, Peoples R China
基金
中国国家自然科学基金;
关键词
gut microbiota; dysbiosis; cancer; fecal microbiota transplantation; therapy; CLOSTRIDIUM-DIFFICILE INFECTION; STEM-CELL TRANSPLANT; PROMOTES INTESTINAL CARCINOGENESIS; BACTEROIDES-FRAGILIS ENTEROTOXIN; FACTOR-KAPPA-B; COLORECTAL-CANCER; GUT MICROBIOTA; HOST-CELLS; DYSBIOSIS CONTRIBUTES; ANTIBIOTIC EXPOSURE;
D O I
10.1002/ijc.32003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The human gut is home to a large and diverse microbial community, comprising about 1,000 bacterial species. The gut microbiota exists in a symbiotic relationship with its host, playing a decisive role in the host's nutrition, immunity and metabolism. Accumulating studies have revealed the associations between gut dysbiosis or some special bacteria and various cancers. Emerging data suggest that gut microbiota can modulate the effectiveness of cancer therapies, especially immunotherapy. Manipulating the microbial populations with therapeutic intent has become a hot topic of cancer research, and the most dramatic manipulation of gut microbiota refers to fecal microbiota transplantation (FMT) from healthy individuals to patients. FMT has demonstrated remarkable clinical efficacy against Clostridium difficile infection (CDI) and it is highly recommended for the treatment of recurrent or refractory CDI. Lately, interest is growing in the therapeutic potential of FMT for other diseases, including cancers. We briefly reviewed the current researches about gut microbiota and its link to cancer, and then summarized the recent preclinical and clinical evidence to indicate the potential of FMT in cancer management as well as cancer-treatment associated complications. We also presented the rationale of FMT for cancer management such as reconstruction of intestinal microbiota, amelioration of bile acid metabolism, and modulation of immunotherapy efficacy. This article would help to better understand this new therapeutic approach for cancer patients by targeting gut microbiota.
引用
收藏
页码:2021 / 2031
页数:11
相关论文
共 139 条
[1]   Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc [J].
Abed, Jawad ;
Emgard, Johanna E. M. ;
Zamir, Gideon ;
Faroja, Mouhammad ;
Almogy, Gideon ;
Grenov, Amalie ;
Sol, Asaf ;
Naor, Ronit ;
Pikarsky, Eli ;
Atlan, Karine A. ;
Mellul, Anna ;
Chaushu, Stella ;
Manson, Abigail L. ;
Earl, Ashlee M. ;
Ou, Nora ;
Brennan, Caitlin A. ;
Garrett, Wendy S. ;
Bachrach, Gilad .
CELL HOST & MICROBE, 2016, 20 (02) :215-225
[2]   Banking on stool despite an uncertain future [J].
Amirtha, Tina .
SCIENCE, 2016, 352 (6291) :1261-1262
[3]   Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota [J].
Arthur, Janelle C. ;
Perez-Chanona, Ernesto ;
Muehlbauer, Marcus ;
Tomkovich, Sarah ;
Uronis, Joshua M. ;
Fan, Ting-Jia ;
Campbell, Barry J. ;
Abujamel, Turki ;
Dogan, Belgin ;
Rogers, Arlin B. ;
Rhodes, Jonathan M. ;
Stintzi, Alain ;
Simpson, Kenneth W. ;
Hansen, Jonathan J. ;
Keku, Temitope O. ;
Fodor, Anthony A. ;
Jobin, Christian .
SCIENCE, 2012, 338 (6103) :120-123
[4]   Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant [J].
Bajaj, Jasmohan S. ;
Kakiyama, Genta ;
Savidge, Tor ;
Takei, Hajime ;
Kassam, Zain A. ;
Fagan, Andrew ;
Gavis, Edith A. ;
Pandak, William M. ;
Nittono, Hiroshi ;
Hylemon, Phillip B. ;
Boonma, Prapaporn ;
Haag, Anthony ;
Heuman, Douglas M. ;
Fuchs, Michael ;
John, Binu ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
HEPATOLOGY, 2018, 68 (04) :1549-1558
[5]   Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial [J].
Bajaj, Jasmohan S. ;
Kassam, Zain ;
Fagan, Andrew ;
Gavis, Edith A. ;
Liu, Eric ;
Cox, I. Jane ;
Kheradman, Raffi ;
Heuman, Douglas ;
Wang, Jessica ;
Gurry, Thomas ;
Williams, Roger ;
Sikaroodi, Masoumeh ;
Fuchs, Michael ;
Alm, Eric ;
John, Binu ;
Thacker, Leroy R. ;
Riva, Antonio ;
Smith, Mark ;
Taylor-Robinson, Simon D. ;
Gillevet, Patrick M. .
HEPATOLOGY, 2017, 66 (06) :1727-1738
[6]   Treating Clostridium difficile Infection With Fecal Microbiota Transplantation [J].
Bakken, Johan S. ;
Borody, Thomas ;
Brandt, Lawrence J. ;
Brill, Joel V. ;
Demarco, Daniel C. ;
Franzos, Marc Alaric ;
Kelly, Colleen ;
Khoruts, Alexander ;
Louie, Thomas ;
Martinelli, Lawrence P. ;
Moore, Thomas A. ;
Russell, George ;
Surawicz, Christina .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (12) :1044-1049
[7]   Fecal Microbiota Transplantation in Patients With Cancer Undergoing Treatment [J].
Blackburn, Lisa M. ;
Bales, Andrea ;
Caldwell, Mary ;
Cordell, Lee ;
Hamilton, Susan ;
Kreider, Haley .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (01) :111-114
[8]   The Bacteroides fragilis Toxin Gene Is Prevalent in the Colon Mucosa of Colorectal Cancer Patients [J].
Boleij, Annemarie ;
Hechenbleikner, Elizabeth M. ;
Goodwin, Andrew C. ;
Badani, Ruchi ;
Stein, Ellen M. ;
Lazarev, Mark G. ;
Ellis, Brandon ;
Carroll, Karen C. ;
Albesiano, Emilia ;
Wick, Elizabeth C. ;
Platz, Elizabeth A. ;
Pardoll, Drew M. ;
Sears, Cynthia L. .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) :208-215
[9]   The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease [J].
Boleij, Annemarie ;
Tjalsma, Harold .
LANCET INFECTIOUS DISEASES, 2013, 13 (08) :719-724
[10]   Colonization of the Human Gut by E. coli and Colorectal Cancer Risk [J].
Bonnet, Mathilde ;
Buc, Emmanuel ;
Sauvanet, Pierre ;
Darcha, Claude ;
Dubois, Damien ;
Pereira, Bruno ;
Dechelotte, Pierre ;
Bonnet, Richard ;
Pezet, Denis ;
Darfeuille-Michaud, Arlette .
CLINICAL CANCER RESEARCH, 2014, 20 (04) :859-867